- Home
- PHVS vs RSKD Comparison
PHVS vs RSKD Comparison
Compare PHVS & RSKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- RSKD
- Stock Information
- Founded
- PHVS 2015
- RSKD 2012
- Country
- PHVS Switzerland
- RSKD United States
- Employees
- PHVS N/A
- RSKD N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- RSKD EDP Services
- Sector
- PHVS Health Care
- RSKD Technology
- Exchange
- PHVS Nasdaq
- RSKD Nasdaq
- Market Cap
- PHVS 980.9M
- RSKD 790.1M
- IPO Year
- PHVS 2021
- RSKD 2021
- Fundamental
- Price
- PHVS $22.32
- RSKD $5.02
- Analyst Decision
- PHVS Buy
- RSKD Hold
- Analyst Count
- PHVS 6
- RSKD 8
- Target Price
- PHVS $37.17
- RSKD $6.03
- AVG Volume (30 Days)
- PHVS 33.8K
- RSKD 484.6K
- Earning Date
- PHVS 08-13-2025
- RSKD 08-13-2025
- Dividend Yield
- PHVS N/A
- RSKD N/A
- EPS Growth
- PHVS N/A
- RSKD N/A
- EPS
- PHVS N/A
- RSKD N/A
- Revenue
- PHVS N/A
- RSKD $333,495,000.00
- Revenue This Year
- PHVS N/A
- RSKD $5.92
- Revenue Next Year
- PHVS N/A
- RSKD $9.38
- P/E Ratio
- PHVS N/A
- RSKD N/A
- Revenue Growth
- PHVS N/A
- RSKD 9.30
- 52 Week Low
- PHVS $11.51
- RSKD $3.94
- 52 Week High
- PHVS $25.76
- RSKD $6.56
- Technical
- Relative Strength Index (RSI)
- PHVS 73.31
- RSKD 48.95
- Support Level
- PHVS $17.63
- RSKD $4.82
- Resistance Level
- PHVS $19.00
- RSKD $5.27
- Average True Range (ATR)
- PHVS 1.20
- RSKD 0.14
- MACD
- PHVS 0.35
- RSKD 0.01
- Stochastic Oscillator
- PHVS 92.15
- RSKD 35.14
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About RSKD Riskified Ltd.
Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.